Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for.

Slides:

Advertisements

Similar presentations

Validity of the LaFarge equation for estimation of oxygen consumption in ventilated children with congenital heart disease younger than 3 years—A revisit.

Advertisements

Effects of β-erythropoietin treatment on left ventricular remodeling, systolic function, and B-type natriuretic peptide levels in patients with the cardiorenal.

Downstream coronary effects of drug-eluting stents

Comparison of Low Versus High (>40 mm Hg) Pulse Pressure to Predict the Benefit of Cardiac Resynchronization Therapy for Heart Failure (from the Multicenter.

Journal of Cardiac Failure

Identifying patients for advanced heart failure therapy by screening patients with cardiac resynchronization therapy or implantable cardioverter-defibrillator:

Quality of life and chronic heart failure therapy guided by natriuretic peptides: Results from the ProBNP Outpatient Tailored Chronic Heart Failure Therapy.

Balloon aortic valvuloplasty in the era of transcatheter aortic valve replacement: Acute and long-term outcomes Hélène Eltchaninoff, MD, Eric Durand,

A clinically practicable diagnostic score for metabolic syndrome improves its predictivity of diabetes mellitus: The Gruppo Italiano per lo Studio della.

Ali Ahmed, MD, MPH, Gilbert J. Perry, MD, Jerome L. Fleg, MD, Thomas E

Previous coronary stents do not increase early and long-term adverse outcomes in patients undergoing off-pump coronary artery bypass grafting: A propensity-matched.

CHronic use of Amiodarone aGAinSt Implantable cardioverter-defibrillator therapy for primary prevention of death in patients with Chagas cardiomyopathy.

Incremental and independent value of cardiopulmonary exercise test measures and the Seattle Heart Failure Model for prediction of risk in patients with.

Can the Seattle Heart Failure Model Be Used to Risk-stratify Heart Failure Patients for Potential Left Ventricular Assist Device Therapy? Wayne C. Levy,

Variation among hospitals in selection of higher-cost, “higher-tech,” implantable cardioverter-defibrillators: Data from the National Cardiovascular Data.

Automatic Optimization of Cardiac Resynchronization Therapy Using SonR—Rationale and Design of the Clinical Trial of the SonRtip Lead and Automatic AV-VV.

Admission heart rate and in-hospital outcomes in patients hospitalized for heart failure in sinus rhythm and in atrial fibrillation Anh L. Bui, MD, Maria.

Risk reduction of cardiac events by screening of unknown asymptomatic coronary artery disease in subjects with type 2 diabetes mellitus at high cardiovascular.

National evaluation of adherence to β-blocker therapy for 1 year after acute myocardial infarction in patients with commercial health insurance Judith.

Rationale and design of a randomized clinical trial to assess the safety and efficacy of frequent optimization of cardiac resynchronization therapy: The.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

James M. Beattie, MBChB, FRCP, James N. Kirkpatrick, MD, Kristen K

Elena Biagini, MD, Arend F. L

The American Association for Thoracic Surgery 2016 Ethics Forum: Cost-effectiveness and the ethics of left ventricular assist device therapy John W.C.

CHA2DS2-VASc Score Is Directly Associated with the Risk of Pulmonary Embolism in Patients with Atrial Fibrillation Walid Saliba, MD, MPH, Gad Rennert,

Volume 14, Issue 9, Pages (September 2017)

The Impact of Race on the Prognosis of Preclinical Diastolic Dysfunction: A Large Multiracial Urban Population Study Jian Shan, MD, Lili Zhang, MD, MSc,

Susan C. Scott, MD, Nathan A. Pennell, MD, PhD

Antibiotic Therapy and 48-Hour Mortality for Patients with Pneumonia

Misconceptions and Facts About Hypertrophic Cardiomyopathy

Surgical treatment is decisive for outcome in chondrosarcoma of the chest wall: A population-based Scandinavian Sarcoma Group study of 106 patients Björn.

Volume 6, Issue 12, Pages (December 2009)

Andre J. Gauri, MD, Andrew Davis, MD, Thomas Hong, MD, Martin C

Belinda Gray et al. JCHF 2013;1:

Patient and Graft Survival Following Kidney Transplantation in Recipients With Cystinosis: A Cohort Study Rebecca A. Spicer, MBChB, Philip A. Clayton,

Zachary R. McCaw, AM, Ariela R

Weekday and Survival After Pulmonary Resections for Lung Cancer

Centers for Disease Control “increased-risk” organ donor: Not so risky? Francis D. Pagani, MD, PhD The Journal of Thoracic and Cardiovascular Surgery

Volume 15, Issue 10, Pages e253-e274 (October 2018)

Volume 8, Issue 12, Pages (December 2011)

Ethnic and racial disparities in cardiac resynchronization therapy

Recurrence of mitral regurgitation after partial versus complete mitral valve ring annuloplasty for functional mitral regurgitation Michael H. Kwon,

Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement Ole Lund, MD, PhD, Martin Bland,

Volume 14, Issue 12, Pages (December 2017)

Shannon M. Dunlay, MD, MS, Naveen L. Pereira, MD, Sudhir S

A Prognostic Model to Predict Mortality among Non–Small-Cell Lung Cancer Patients in the U.S. Military Health System Jie Lin, PhD, MPH, Corey A. Carter,

Transvenous versus transthoracic cardioverter-defibrillator implantation: A comparative analysis of morbidity, mortality, and survival David M. Shahian,

Volume 12, Issue 10, Pages (October 2015)

Clinical utility of CHADS2 and CHA2DS2-VASc scoring systems for predicting postoperative atrial fibrillation after cardiac surgery Su-Kiat Chua, MD,

Institutional volume and the effect of recipient risk on short-term mortality after orthotopic heart transplant George J. Arnaoutakis, MD, Timothy J.

Volume 15, Issue 1, Pages (January 2018)

Arman Kilic, MD, Eric S. Weiss, MD, MPH, Jeremiah G

Impact of low donor to recipient weight ratios on cardiac transplantation Senthil Nathan Jayarajan, MD, Sharven Taghavi, MD, Eugene Komaroff, PhD, Abeel.

Volume 8, Issue 3, Pages (March 2011)

Impact of generator replacement on the risk of Fidelis lead fracture

James O. O’Neill, MB, Randall C

Dipyridamole-thallium scintigraphy predicts perioperative and long-term survival after major vascular surgery Bruce S. Cutler, MD, Robert C. Hendel,

Impact of Tumor Size on Local Control and Pneumonitis After Stereotactic Body Radiation Therapy for Lung Tumors Sean M. Parker, BS, R. Alfredo Siochi,

Insertion of a left ventricular assist device in patients without thorough transplant evaluations: a worthwhile risk? Mathew Williams, MD, Jennifer Casher,

Saadia Sherazi et al. JACEP 2015;1:74-80

Jeffrey H. Shuhaiber, MD, Jeff Moore, MS, David B. Dyke, MD

The future of cardiac surgery training: A survival guide

Surgical outcomes after cardiac surgery in liver transplant recipients

External model validation of binary clinical risk prediction models in cardiovascular and thoracic surgery Graeme L. Hickey, PhD, Eugene H. Blackstone,

Should heart transplantation be considered as a treatment option for patients aged 70 years and older? Jeffrey A Morgan, MD, Ranjit John, MD, Donna M.

Axillary-to-carotid artery bypass grafting for symptomatic severe common carotid artery occlusive disease Joseph P. Archie, PhD, MD Journal of Vascular.

Transcatheter aortic valve implantation versus surgical aortic valve replacement: A propensity score analysis in patients at high surgical risk Lenard.

Kalpaj Parekh, MD, Bryan F. Meyers, MD, G

Volume 16, Issue 6, Pages (June 2019)

(A). (A). Kaplan-Meier plot of event-free survival in 27 LMNA mutation carriers and 78 DCM control patients. Death, heart transplantation, resuscitation.

Presentation transcript:

Utility of the Seattle Heart Failure Model in patients with cardiac resynchronization therapy and implantable cardioverter defibrillator referred for heart transplantation Ulrik Sartipy, MD, PhD, Ayumi Goda, MD, Melana Yuzefpolskaya, MD, Donna M. Mancini, MD, Lars H. Lund, MD, PhD American Heart Journal Volume 168, Issue 3, Pages 325-331 (September 2014) DOI: 10.1016/j.ahj.2014.03.025 Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 1 Event-free survival for SHFM risk strata. Kaplan-Meier event-free survival for SHFM low-, medium-, and high-risk strata in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 2 Observed versus predicted event-free survival. Observed versus SHFM-predicted event-free survival at 1, 2, and 3 years in low-, medium-, and high-risk strata in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 3 Calibration plot. Calibration plot showing the mean predicted probability of event-free survival against the observed proportion of event-free survival for the calculated SHFM integer score at 1, 2, and 3 years. The dashed line shows the ideal calibration line. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions

Figure 4 Seattle Heart Failure Model score and predicted and observed survival. Distribution of the calculated SHFM integer score and its relationship to the predicted and observed survival in 382 patients with CRT and/or ICD referred for heart transplantation. American Heart Journal 2014 168, 325-331DOI: (10.1016/j.ahj.2014.03.025) Copyright © 2014 Mosby, Inc. Terms and Conditions